Thank you for sharing!

Your article was successfully shared with the contacts you provided.

The emergence of a pair of “wonder drugs” that cure Hepatitis C are driving up drug spending costs for employer sponsored health plans. But because of the effectiveness of the drugs, they are reducing overall spending in the long run.

Dan Cook


Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.